Benzinga | Aug 5, 2021 07:46AM EDT

Kala Pharmaceuticals Q2 EPS $(0.57) Misses $(0.45) Estimate, Sales $3.10M Miss $5.33M Estimate

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.45) by 26.67 percent. This is a 35.71 percent decrease over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $3.10 million which missed the analyst consensus estimate of $5.33 million by 41.84 percent. This is a 272.15 percent increase over sales of $833.00 thousand the same period last year.